Your browser doesn't support javascript.
loading
B-cell acute lymphoblastic leukemia in patients with chronic lymphocytic leukemia treated with lenalidomide.
Fürstenau, Moritz; Fink, Anna Maria; Schilhabel, Anke; Weiss, Jonathan; Robrecht, Sandra; Eckert, Robert; de la Serna, Javier; Crespo, Marta; Coscia, Marta; Vitale, Candida; Böttcher, Sebastian; Weppner, Gesche; Ritgen, Matthias; Stilgenbauer, Stephan; Tausch, Eugen; Fischer, Kirsten; Hallek, Michael; Eichhorst, Barbara; Brüggemann, Monika; Herling, Carmen D.
Afiliação
  • Fürstenau M; Department I of Internal Medicine, Center for Integrated Oncology Aachen Bonn Cologne Duesseldorf, German CLL Study Group, University Hospital Cologne, University of Cologne, Cologne, Germany.
  • Fink AM; Department I of Internal Medicine, Center for Integrated Oncology Aachen Bonn Cologne Duesseldorf, German CLL Study Group, University Hospital Cologne, University of Cologne, Cologne, Germany.
  • Schilhabel A; Department II of Internal Medicine, Campus Kiel, University of Schleswig-Holstein, Kiel, Germany.
  • Weiss J; Department I of Internal Medicine, Center for Integrated Oncology Aachen Bonn Cologne Duesseldorf, German CLL Study Group, University Hospital Cologne, University of Cologne, Cologne, Germany.
  • Robrecht S; Department I of Internal Medicine, Center for Integrated Oncology Aachen Bonn Cologne Duesseldorf, German CLL Study Group, University Hospital Cologne, University of Cologne, Cologne, Germany.
  • Eckert R; Onkologische Schwerpunktpraxis Esslingen, Esslingen, Germany.
  • de la Serna J; Servicio de Hematología, Hospital Universitario 12 de Octubre, Madrid, Spain.
  • Crespo M; Vall d'Hebron Institute of Oncology (VHIO), Vall d'Hebron University Hospital, Barcelona, Spain.
  • Coscia M; Department of Medicine, Universitat Autònoma de Barcelona, Bellaterra, Barcelona, Spain.
  • Vitale C; University Division of Hematology, Azienda Ospedaliero-Universitaria Città della Salute e della Scienza di Torino and Department of Molecular Biotechnology and Health Sciences, University of Torino, Torino, Italy.
  • Böttcher S; University Division of Hematology, Azienda Ospedaliero-Universitaria Città della Salute e della Scienza di Torino and Department of Molecular Biotechnology and Health Sciences, University of Torino, Torino, Italy.
  • Weppner G; Department II of Internal Medicine, Campus Kiel, University of Schleswig-Holstein, Kiel, Germany.
  • Ritgen M; Medical Clinic III, Hematology, Oncology and Palliative Medicine, Rostock University Medical Center, Rostock, Germany.
  • Stilgenbauer S; Department II of Internal Medicine, Campus Kiel, University of Schleswig-Holstein, Kiel, Germany.
  • Tausch E; Department II of Internal Medicine, Campus Kiel, University of Schleswig-Holstein, Kiel, Germany.
  • Fischer K; Department of Internal Medicine III, University of Ulm, Ulm, Germany.
  • Hallek M; Department of Internal Medicine I, Saarland University Medical School, Homburg/Saar, Germany; and.
  • Eichhorst B; Department of Internal Medicine III, University of Ulm, Ulm, Germany.
  • Brüggemann M; Department I of Internal Medicine, Center for Integrated Oncology Aachen Bonn Cologne Duesseldorf, German CLL Study Group, University Hospital Cologne, University of Cologne, Cologne, Germany.
  • Herling CD; Department I of Internal Medicine, Center for Integrated Oncology Aachen Bonn Cologne Duesseldorf, German CLL Study Group, University Hospital Cologne, University of Cologne, Cologne, Germany.
Blood ; 137(16): 2267-2271, 2021 04 22.
Article em En | MEDLINE | ID: mdl-33512465
Assuntos
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Leucemia Linfocítica Crônica de Células B / Leucemia-Linfoma Linfoblástico de Células Precursoras / Lenalidomida / Fatores Imunológicos Tipo de estudo: Etiology_studies / Incidence_studies / Prognostic_studies / Risk_factors_studies Limite: Female / Humans / Male Idioma: En Revista: Blood Ano de publicação: 2021 Tipo de documento: Article País de afiliação: Alemanha
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Leucemia Linfocítica Crônica de Células B / Leucemia-Linfoma Linfoblástico de Células Precursoras / Lenalidomida / Fatores Imunológicos Tipo de estudo: Etiology_studies / Incidence_studies / Prognostic_studies / Risk_factors_studies Limite: Female / Humans / Male Idioma: En Revista: Blood Ano de publicação: 2021 Tipo de documento: Article País de afiliação: Alemanha